The Chemical and Pharmaceutical Industry in China : Opportunities and Threats for Foreign Companies / edited by Gunter Festel, Udo Oels, Andreas Kreimeyer, Max Zedtwitz.

Springer eBooks

The Chemical Industry in China -- The Global Chemical Industry -- The Petrochemical Industry in China -- Activities of European Chemical Companies in China -- Research and Development in China -- Chemical Industry Parks in China -- Trends in the Chinese Fine Chemicals Market — Opportunities and Threats for the European Fine Chemicals Industry -- Chemicals for China's Chip Industry -- The Pharmaceutical Industry in China -- China's Pharmaceutical Market: Business Environment and Market Dynamics -- Developing the Pharmaceutical Business in China — The Case of Novartis -- China's Approach to Innovative Pharmaceutical R&D: A Review -- Foreign Direct Investment by Multinational Corporations in China — The Pharmaceutical Sector -- Competing in the Chinese Antibiotics Market — Cephalosporins 1982–2000 -- The Experience of Successful European Companies in China -- Swimming Ahead of the Shoal — The History of BASF in Greater China -- Establishing a Competitive Production Network in Asia -- Bayer — A Multinational Committed to China -- Bicoll — The First Sino-German Biotechnology Company -- Ciba Specialty Chemicals in China — Global Direction and Local Expertise -- Degussa: Transforming the China Region -- A Toolbox for China — Lessons from the China Experience of Degussa Construction Chemicals -- DSM in China: In Touch with Evolving Needs in the Specialty Chemicals Market -- Vitamins — Opportunities and Challenges for Both Western and Chinese Producers.

The Chinese market and Chinese companies are of increasing importance for the global chemical and pharmaceutical industry. The book starts with the characterization of the chemical and pharmaceutical industry in China. One central aspect is the political and economic situation in China with its strategic and operational implications for Western chemical and pharmaceutical companies. A major part of the book comprises case studies describing how Western companies like BASF, Bayer, Bicoll, Ciba, Degussa, DSM and Novartis are managing the market entry and investments for further growth in China. The book also analyzes the threat to Western companies in their home markets from Chinese competitors.

Para consulta fuera de la UANL se requiere clave de acceso remoto.